- Home
- OWL vs COO Comparison
OWL vs COO Comparison
Compare OWL & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- COO
- Stock Information
- Founded
- OWL 2020
- COO 1980
- Country
- OWL United States
- COO United States
- Employees
- OWL N/A
- COO N/A
- Industry
- OWL Investment Managers
- COO Ophthalmic Goods
- Sector
- OWL Finance
- COO Health Care
- Exchange
- OWL Nasdaq
- COO Nasdaq
- Market Cap
- OWL 10.6B
- COO 14.2B
- IPO Year
- OWL N/A
- COO N/A
- Fundamental
- Price
- OWL $14.88
- COO $68.96
- Analyst Decision
- OWL Buy
- COO Buy
- Analyst Count
- OWL 15
- COO 11
- Target Price
- OWL $22.50
- COO $79.27
- AVG Volume (30 Days)
- OWL 14.5M
- COO 2.5M
- Earning Date
- OWL 10-30-2025
- COO 12-04-2025
- Dividend Yield
- OWL 6.02%
- COO N/A
- EPS Growth
- OWL 47.85
- COO 13.33
- EPS
- OWL 0.08
- COO 2.04
- Revenue
- OWL $2,745,943,000.00
- COO $4,045,700,000.00
- Revenue This Year
- OWL $17.06
- COO $6.02
- Revenue Next Year
- OWL $21.21
- COO $5.76
- P/E Ratio
- OWL $192.81
- COO $33.83
- Revenue Growth
- OWL 27.24
- COO 6.35
- 52 Week Low
- OWL $14.55
- COO $61.78
- 52 Week High
- OWL $26.73
- COO $107.84
- Technical
- Relative Strength Index (RSI)
- OWL 34.67
- COO 43.29
- Support Level
- OWL $15.37
- COO $68.48
- Resistance Level
- OWL $16.34
- COO $70.12
- Average True Range (ATR)
- OWL 0.65
- COO 1.56
- MACD
- OWL -0.09
- COO -0.53
- Stochastic Oscillator
- OWL 0.61
- COO 19.45
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.